Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

Top 10 search results for "Finishing medication aromasin" in Treatments. To see all results and access other features, sign up for free.

Did you mean finishing meditation aromasin?

Aromasin (Exemestane)

Overview
Aromasin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer after menopause. Aromasin is used as an adjuvant, or… read more

Herceptin (Trastuzumab)

Overview
Herceptin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more

Perjeta (Pertuzumab)

Overview
Perjeta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 therapy… read more

Faslodex (Fulvestrant)

Overview
Faslodex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat estrogen receptor-positive breast cancer in postmenopausal women whose cancer progressed after treatment with… read more

Kadcyla (Ado-Trastuzumab Emtansine)

Overview
Kadcyla is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Kadcyla may be prescribed in cases where trastuzumab and a… read more

Arimidex (Anastrozole)

Overview
Arimidex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in postmenopausal women in cases where the cancer is early-stage and hormone receptor-positive,… read more

Afinitor (Everolimus)

Overview
Afinitor is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat advanced breast cancer in combination with exemestane after treatment with letrozole or anastrozole has failed.… read more

Femara (Letrozole)

Overview
Femara is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat estrogen receptor-positive breast cancer in postmenopausal women. Femara is used as an adjuvant, or post-surgical,… read more

Ado-Trastuzumab Emtansine

Overview
Ado-trastuzumab emtansine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-trastuzumab emtansine may be… read more

Ibrance (Palbociclib)

Overview
Ibrance is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic breast cancer in combination with other medications. Ibrance is prescribed in cases where… read more